$GILD Recent News Earnings boost Micron, drag on

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2014 at 3:18 PM

$GILD Recent News

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 4:07 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 3:59 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 7:21 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Best Buy, Gilead Sciences lead S&P 500 gainers 3:05 p.m. Oct. 10, 2013 - Polya Lesova

Best Biotech Ideas for 2014 23 min ago - Barrons.com
If History Repeats, Biotech Traders Will Have Fun Next Week. Here's Why. 11:56 a.m. Today - TheStreet.com
Stock Market News for January 10, 2014 - Corporate Summary 10:06 a.m. Today - Zacks.com
Don't Underestimate Amgen: Part 1 7:45 a.m. Today - Seeking Alpha
'Fast Money' Recap: Jumping Into Retail 5:00 a.m. Today - TheStreet.com
Healthcare Picks By Drug Type In 2014 8:59 a.m. Jan. 9, 2014 - Seeking Alpha
Nomura starts coverage on multiple biotechs 10:46 a.m. Jan. 8, 2014 - Seeking Alpha
J.P. Morgan Top Biotechnology Stocks to Buy for 2014 7:39 a.m. Jan. 8, 2014 - 247WallSt.com
Enanta Joins Big Leagues With Hepatitis C Drug 6:15 p.m. Jan. 7, 2014 - Investors Business Daily
Top Funds Like Facebook And Health Care Stocks 5:59 p.m. Jan. 7, 2014 - Investors Business Daily
Best Ideas for 2014 (Part 2) 3:29 p.m. Jan. 7, 2014 - RealMoney.com
Ascent of the Fallen Stars 2:24 p.m. Jan. 7, 2014 - Barrons.com
Is the Biotech Boom Over? 10:58 a.m. Jan. 7, 2014 - Barrons.com
Gilead VP of Commercial Operations to retire 7:34 a.m. Jan. 7, 2014 - Seeking Alpha
Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling 6:00 a.m. Jan. 7, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Profiting From Down Days 8:20 p.m. Jan. 6, 2014 - TheStreet.com
Market Hustle: Futures Rise Despite More China Weakness 9:01 a.m. Jan. 6, 2014 - TheStreet.com
The Gilead Rebuttal 8:38 a.m. Jan. 6, 2014 - Seeking Alpha
Citi's top biotech picks include Biogen, Gilead, and Celgene 8:33 a.m. Jan. 6, 2014 - Seeking Alpha
Positioning For 2014 In The Health Care Sector 8:04 a.m. Jan. 6, 2014 - Seeking Alpha

Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera(R) for Patients Switching from a Stable Regimen 4:30 p.m. Dec. 13, 2013 - BusinessWire
HealthStat Rx: Curing Hepatitis C (HCV) With Confidence 10:07 a.m. Dec. 12, 2013 - BusinessWire
Here to Track Insider Trading of Gilead Sciences, Microsoft, Halliburton 8:55 a.m. Dec. 11, 2013 - PR Newswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unlikely Collaborators Grants $7.2M to Boost Nonprofits

Massive Boost for Nonprofits Across the United States It's not every day you see millions thrown into nonprofit work without some fanfare, right? Unlikely Collaborators just poured a hefty $7.2 million into the coffers of 52 nonprofit outfits scattered across the nation. This spread isn't just about slapping cash on projects—it's about putting Elizabeth R. Koch's...

American Bitcoin Sees 5% Hike in Satoshis Per Share

Digging Deeper into American Bitcoin's Latest Results Out of the blue, American Bitcoin Corp. (NASDAQ:ABTC) has dropped its third-quarter 2026 financial results, and guess what? It's looking like they've struck gold—or should I say, digital gold. The Miami-based operation is all about stacking those Bitcoins, weaving them into their business model like a knitter with a...

Life with PAH: A Journey of Awareness and Hope

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Greasezilla to Process 15M Gallons of FOG Yearly

Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...

Fleet Management Software: Poised for 251% Growth

Explosive Growth Ahead in Fleet Management Software If you're thinking we're about to see a seismic shift in how fleets are managed, you're spot on. The fleet management software market, worth a modest USD 1.83 billion in 2026, is projected to skyrocket to USD 6.41 billion by 2033. We’re talking a solid 19.6% CAGR here, and that’s not some small potatoes. This isn’t...

Defense Contractors Eye Larger Backlogs Amid Funding Uncertainty

Playing Chicken with Federal Deadlines We've got ourselves a situation where defense contractors are juggling bigger backlogs while the clock ticks down to a looming federal funding deadline on December 11. If this sounds like a high-stakes game of chicken, it's because it is. No one knows if Congress will stitch things up before the stopgap funding dries up. Hell, maybe...

NOVOS Trial Boosts Vascular Health: A New Horizon

Watch Out, Aging: NOVOS Is Making Waves Aging ain't what it used to be, and longevity's becoming the golden chalice of the wellness world. Surrounded by a sea of questionably effective supplements, NOVOS, a biotech firm focused on prolonging the healthy years of life, steps up with some hard evidence. Their STAMINA trial, published in the European Heart Journal Open,...

Stellar Snacks Shakes Up Pretzel Sector with Bold Launch

Stellar Snacks' audacious venture into olive oil-based pretzels Ever thought pretzels would stir up a storm? Well, Stellar Snacks sure did. They're celebrating a blockbuster year by rolling out a brand-new line of olive oil-baked pretzel braids across Sprouts Farmers Market nationwide. This isn't just any rollout. It's a carefully crafted endeavor tailored to redefine how...

Zillow Eases the FHA Down Payment Burden

A New Financial Lifeline for Homebuyers In a market where finding a foothold in the housing game feels like scaling Everest without ropes, Zillow Home Loans has tossed a lifeline to potential homeowners. Their latest move might just be what many house hunters needed to hear—offering a hand where it’s been missing for years: down payment assistance for FHA loans. The...

Omnissa Expands AI Sovereignty: New Markets, New Control

Omnissa Rolls Out AI Sovereignty Across New Markets In the world of AI, where data is king and control is the crown, Omnissa is making bold moves with its latest expansion announcement. The company's Sovereign Solution (OSS) is now reaching into six fresh markets across Europe and Asia, offering organizations a vital grip on their digital domains like never before. Talk...